Go Ad-Free
    My Alerts
    Moneycontrol
    Moneycontrol PRO
    Outskill Genai
    HomeNewsBusinessAnnouncementsZydus receives final approval from USFDA for Tizanidine tablets USP

    Zydus receives final approval from USFDA for Tizanidine tablets USP

    Zydus Cadila has received a final approval from the USFDA to market Tizanidine tablets USP in the strength of 2 mg and 4 mg.

    March 13, 2018 / 10:55 IST
       
       
      26 Aug, 2025 12:21
      Volume
      Todays L/H
      More

      Zydus Cadila has received a final approval from the USFDA to market Tizanidine tablets USP in the strength of 2 mg and 4 mg.

      At 10:54 hrs Cadila Healthcare was quoting at Rs 394.75, up Rs 5.35, or 1.37 percent.

      The share touched its 52-week high Rs 558.00 and 52-week low Rs 373.05 on 12 June, 2017 and 06 February, 2018, respectively.

      Currently, it is trading 29.26 percent below its 52-week high and 5.82 percent above its 52-week low.

      Market capitalisation stands at Rs 40,412.24 crore.
      Source : BSE

      Read More Read More

      first published: Mar 13, 2018 10:55 am

      Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!

      Subscribe to Tech Newsletters

      • On Saturdays

        Find the best of Al News in one place, specially curated for you every weekend.

      • Daily-Weekdays

        Stay on top of the latest tech trends and biggest startup news.

      Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347